The Burden of Lyme Disease (BOLD) in a Pandemic - Insights From an Online Cross-sectional and Prospective Cohort Survey

Recruiting

Observational StudyThe Burden of Lyme Disease (BOLD) in a Pandemic - Insights From an Online Cross-sectional and Prospective Cohort Survey

Sponsor:

Dr. Daniel Cameron & Associates

Code:

NCT05312619

Conditions

COVID-19

Lyme Disease

COVID-19 Vaccine

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Cross sectional survey

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Dr. Daniel Cameron & Associates on 2022-04-05.